Sentinel Lymph Node Evaluation in Early-Stage Vulvar Cancer

Area of Science:

• Gynecologic Oncology
• Surgical Oncology

Background:

• Full inguinofemoral lymph node dissection (IFLND) for early-stage vulvar cancer is linked to significant postoperative complications.
• These complications include wound breakdown, lymphedema, lymphocyst formation, and infection, impacting patient morbidity.

Purpose of the Study:

• To evaluate sentinel lymph node dissection (SLND) as a less morbid alternative to IFLND in select early-stage vulvar cancer patients.
• To identify patient criteria and surgical techniques suitable for SLND.

Main Methods:

• SLND involves identifying and dissecting sentinel lymph nodes using techniques like radiocolloid lymphoscintigraphy with blue dye or near-infrared imaging with indocyanine green.
• Patient selection criteria include unifocal tumors <4cm, clinically negative nodes, and no prior inguinofemoral surgery.

Main Results:

• SLND is presented as a safe and effective alternative to IFLND, associated with reduced postoperative complications.
• The procedure has demonstrated cost-effectiveness, particularly when considering the costs of managing perioperative complications.

Conclusions:

• SLND is a viable alternative to IFLND for carefully selected early-stage vulvar cancer patients, offering a less morbid surgical option.
• Further prospective studies are warranted to compare different SLND techniques and assess quality of life outcomes.